Laser photocoagulation for proliferative diabetic retinopathy

Area of Science:

• Ophthalmology
• Diabetology
• Medical Interventions

Background:

• Diabetic retinopathy (DR) is a diabetes complication damaging retinal blood vessels.
• Proliferative diabetic retinopathy (PDR) involves harmful new blood vessel growth.
• Laser photocoagulation aims to halt neovascularization and preserve vision in DR.

Purpose of the Study:

• To evaluate laser photocoagulation efficacy for diabetic retinopathy.
• Comparison against no treatment or deferred treatment interventions.
• Assessment of visual acuity loss and disease progression.

Main Methods:

• Systematic review of randomized controlled trials (RCTs).
• Inclusion criteria: Laser photocoagulation vs. no/deferred treatment for DR.
• Primary outcome: Loss of ≥15 letters of best-corrected visual acuity (BCVA) at 12 months.

Main Results:

• Laser photocoagulation showed no significant difference in BCVA loss at 12 months (RR 0.99, 95% CI 0.89-1.11).
• Reduced risk of severe visual loss by over 50% at 12 months (RR 0.46, 95% CI 0.24-0.86).
• Decreased risk of DR progression (RR 0.49, 95% CI 0.37-0.64) and vitreous hemorrhage (RR 0.56, 95% CI 0.37-0.85).

Conclusions:

• Laser photocoagulation is beneficial for treating proliferative diabetic retinopathy.
• Evidence quality is moderate to low, influenced by historical trial reporting.
• Future research should explore combining laser with anti-VEGF therapies.